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ABSTRACT 
An opportunistic pathogen, Candida albicans, is commonly found in humans as a 
commensal organism populating the skin, oral cavity, gastrointestinal, and urogenital tract. 
However in immunocompromised patients, C. albicans colonizes epithelial and non-epithelial 
tissues, giving rise to mucosal and bloodstream infections. The pathogenesis of C. albicans has 
not been fully understood and the available treatments for Candida infections are still limited. 
Previous studies have shown that a subset of genes encoding putative Zn(II)2Cys6 transcription 
factors, ZCF, is only expanded in pathogenic yeast and might be involved in C. albicans’s 
virulence. This study utilizes ex vivo and in vitro approaches to characterize select ZCFs in 
macrophage cells and various stress environments. The findings suggest that these ZCFs may be 
key pathogenic determinants in C. albicans and may provide potential fungal-specific drug 
targets.     
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INTRODUCTION 
 
Pathogenicity of Candida albicans 
Candida albicans is a polymorphic fungus commonly found as a commensal organism in 
the human microbiome. In healthy individuals, it populates many areas of the body including the 
skin, oral cavity, gastrointestinal, and urogenital tract (Noble et al. 2010). However, when the 
host’s immunity is compromised, C. albicans can become pathogenic and cause a variety of 
diseases. The diseases range from superficial, non-life threatening infections such as oral thrush 
and vaginal infections to fatal bloodstream infections (candidemia) in severe cases of 
immunodeficiency, it may potentially invade all body sites and important organs like the kidney 
and brain (Vandeputte et al. 2011). The following groups of people are the most susceptible to 
C. albicans infections due to their weakened immune systems: AIDS/HIV-infected individuals, 
patients undergoing anticancer treatment, patients having transplantation therapies and 
individuals who have implanted medical devices (Fox and Nobile 2012). Along with other 
Candida species, C. albicans is notorious for being the fourth most common cause of nosocomial 
bloodstream infections. According to Brown et al. (2012), the mortality rates for worldwide 
case of Candida infections or candidiasis range between 46-75% in infected populations.   
Gow and Calderone (2002) states that Candida infection occurs as the results of 
weakening of host defenses and invasiveness of C. albicans. When the host’s immune system 
becomes deficient, C. albicans utilizes several key virulence factors to invade and infect the host. 
Cell surface adhesion proteins called adhesins assist C. albicans to establish contact with and 
colonize the host’s epithelial cells. C. albicans also secretes hydrolytic enzymes such as aspartyl 
proteinases and phospholipases by digesting the host’s cell membrane for tissue invasion and 
degrading host’s surface molecules to reinforce adhesion (Hube and Naglik 2002). It is believed 
that morphogenesis benefits C. albicans during invasion and dissemination. C. albicans exists as a 
hyphal form for tissue invasion and switches to its yeast form when disseminating (Brown 
2002). The phenomenon of phenotype switching involves the changes in the C. albicans’s 
expression of cell surface antigens, tissue affinities of the organism, enzyme production, and 
drug sensitivity to adapt to a range of physiological extremes within the host (Calderone and 
 2 
Fonzi 2001). In addition, C. albicans also produces biofilm and secondary metabolic signals such 
as farnesol as virulence factors (Ghosh et al. 2010).  
One reason that accounts for the high cases of Candida infection is the limited number 
of ways to treat these infections. The current attempts to treat candidiasis and candidemia 
involve the use of antifungal agents that target C. albicans’s cell structure. The antifungal agents 
are divided into four major compound classes: polyenes (amphotericin B and nystatin), azoles 
(fluconazole, itraconazole, and voriconazole), pyrimidine analogues (5-fluorocytosine), and 
echinocandins (caspofungin) (Vandeputte et al. 2011). Their functions and mode of actions are 
shown in Figure 1. Azole drugs, like fluconazole (FLU) in Figure 1A, target the biosynthesis of 
ergosterol, which is the main component of plasma membrane structure specific to yeast 
(MacPherson et al. 2005). Polyenes, in Figure 1B, bind to ergosterol and compromise the plasma 
membrane integrity, allowing 5-fluorocytosine drugs to enter and inhibit the nucleotide 
biosynthesis (Mukherjee et al. 2005). Echinocandins, in Figure 1D, act by inhibiting the synthesis 
of 1,3-β-D-glucan, a component of fungal cell wall, so to allow other antifungal agents to enter 
the cell (Barker and Rogers 2006).  
 
 
Figure 1. The mode of actions of antifungal drugs. Reprinted from Mukherjee et al. (2005) 
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In general, azoles are preferred over other antifungal agents to treat C. albicans 
infections due to their lower toxicity to the host, improved efficacy, and availability in both 
topical and oral form (Znaidi et al. 2009). However, the current antifungal treatments only 
target limited parts of C. albicans and do not guarantee full recovery for the infected individuals. 
Moreover, repeated and prolonged use of antifungal agents leads to resistance. In a recent 
report from the US Centers for Disease Control and Prevention (2013), an increasing incidence 
of Candida infections was reported from resistance of azole and echinocandins drugs. This issue 
has gathered attention and has become a serious public health threat. Due to these reasons, it 
is important to seek alternate ways to treat Candida infections and gain a better understanding 
of Candida’s pathogenesis, especially the pathogenesis of C. albicans.    
 
Transcription Factors and Zinc Finger Protein 
Several studies have been conducted to determine other possible C. albicans’s virulence 
factors; this includes a previous screening done by Chiasson et al. (2010) that identified four 
novel genes as potential virulence factors, namely orf19.6713, orf19.1219, DOT4, and ZCF15. 
The last kind, ZCF15 particularly is interesting since it is a transcription factor that can be 
implicated in various metabolic pathways. Transcription factors (TFs) use signals from their 
surrounding and send adapted responses by modulating the gene transcription (Vandeputte et 
al. 2011). They can be associated with various metabolism processes such as DNA replication, 
repair, and transcription gene control.   
TFs are categorized into different families based on their DNA binding domains. Some 
of these DNA binding domains are fungal helix-loop-helix (HLH), helix-turn-helix (HTH), high 
mobility group (HMG) box, basic region-leucine zipper (bZIP), MADS box, TEA/ATTS domain, 
copper DNA binding, and heat shock transcription factor (HSTF) (Maicas et al. 2005). One 
particular subfamily of TFs, zinc finger proteins, utilizes zinc atoms for DNA binding. These 
zinc-binding proteins form one of the largest families of transcriptional regulators in eukaryotes 
due to their variable secondary structures and functional diversity (MacPherson et al. 2006). 
The motif of zinc finger protein was first identified in Xenopus’s TFIIIA in 1985. When 
viewed on its 3D protein structure, a “finger-like” structure can be seen in the DNA binding 
domain, hence the term “zinc finger” protein is introduced (MacPherson et al. 2006). Cysteine 
or histidine residues coordinate the zinc atoms in this TF to stabilize the domain and contribute 
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to proper protein structure and function. Other than binding to DNA, zinc finger proteins also 
bind to RNA for physiological processes such as mediating protein-protein interactions, 
chromatic remodeling, protein chaperoning, lipid binding, and zinc sensing (MacPherson et al. 
2006). Based on the zinc-binding motifs, the DNA- and RNA-binding zinc finger proteins can be 
classified into three classes: 
 
Zinc finger class Subclass(es) Consensus amino acid sequence Example 
I (C2H2) FOG (C2HC)  Cys-X2-4-Cys-X12-His-X3-5-His  Xenopus TFIIIA  
II (C4) GATA, nuclear 
receptors, LIM (C3H)  
Cys-X2-Cys-Xn-Cys-X2-Cys-Xn-Cys-X2-
Cys-Xn-Cys-X2-Cys  
Glucocorticoid 
receptor 
III (C6)  Cys-X2-Cys-X6-Cys-X5-12-Cys-X2-Cys-
X6-8-Cys  
S. cerevisiae Gal4p  
Table 1. Different classes of zinc finger proteins. Reprinted from MacPherson et al. (2006) 
 
Compared to the other classes, the class III zinc finger proteins are special because they 
are only specific to fungi. The DNA-binding domain (DBD) has highly conserved the cysteine 
motif that was first discovered in Saccharomyces cerevisiae (Maicas et al. 2005). The motif 
comprises of six cysteine residues bound to two zinc atoms with the pattern of Cys-X2 -Cys-
X6-Cys-X5-16-Cys-X2-Cys-X6-8-Cys, hence marked the origin of the name zinc cluster/zinc 
binuclear cluster/Zn(II)2Cys6/Zn2C6 proteins (MacPherson et al. 2006). For the purpose of this 
study, this motif will be referred as Zn(II)2Cys6. As can be seen in Figure 2, the six cysteine 
residues maintain the structure of the protein and coordinate the folding of the DBD by binding 
with two zinc atoms in the first and fourth cysteine residue, Cys1 and Cys4 that form a metal-
binding domain. The other cysteine residues are present as terminal ligands (Maicas et al. 2005). 
In the sequence motif, each cysteine residue is separated by “X”, which symbolizes amino acid 
residues. The subscripts that follow “X” account for the amount of amino acid residue. For 
example, Cys1 and Cys2 are separated by two amino acid residues and is written like Cys1-X2-
Cys2; Cys2 and Cys3 by six residues, Cys2-X6-Cys3, and so on. Cys3-Cys4 and Cys5-Cys6 have 
variable separation of 5-16 and 6-8 amino acid residues respectively (Maicas et al. 2005).  
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Figure 2. Zn(II)2Cys6 motif in S. cerevisiae’s Gal4p. The yellow highlights in the amino acid sequence show the 
cysteine residues conserved in the motif. The red highlights show lysine residues that bind with DNA. Adapted 
from Campbell et al. (2008) 
 
S. cerevisiae’s Gal4p is the best-studied member of this protein class that acts as a 
transcription gene activator for galactose catabolism (Schillig and Morschhauser 2013). It has 
lysine residues located at positions 17 and 18 that bind with DNA in the recognition site 
(Campbell et al. 2008). A full genome analysis on S. cerevisiae had revealed 55 TFs having the 
Zn(II)2Cys6 motif, making this class as one of the largest in yeast (MacPherson et al. 2006). In C. 
albicans, the Zn(II)2Cys6 TFs control the expression of certain virulence factors and may allow 
for the development of resistance to antifungal drugs (Schillig and Morschhauser 2013). The 
Zn(II)2Cys6 TFs can also be found in other fungal organisms such as Kluyveromyces lactis, fission 
yeast Schizosaccharomyces pombe, and another human pathogen Aspergillus nidulans (MacPherson 
et al. 2006).  
 Zn(II)2Cys6 TFs must be localized to the nucleus to perform their functions as 
transcriptional regulators either to activate or repress transcription of certain genes 
(MacPherson et al. 2006). The proteins can be classified based on their initial location within the 
cell. The first group is permanently present in the nucleus and constitutively binds to the target 
promoters. Its activity is controlled by the direct interaction of surrounding molecules, creating 
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“condition-invariant” regulators (MacPherson et al. 2006). The second group is present in 
cytoplasm and must be imported into the nucleus upon activation. The nuclear import involves 
many exclusive pathways and the transport is mediated through nuclear pores in which soluble 
transport receptors bind to nuclear localization signals on target molecules (MacPherson et al. 
2006).  
 
Zinc Cluster Transcription Factor (ZCF) 
 Schillig and Morschhauser (2013) analyzed the C. albicans genomes and identified 80 TFs 
with Zn(II)2Cys6 motif that might be involved in cellular processes such as metabolism of sugar 
and amino acids, multi-drug resistance, control of meiosis, cell wall architecture, regulation of 
invasive filamentous growth, and phenotypic switching (Maicas et al. 2005). These TFs are still 
yet to be characterized, but after looking at sequence comparisons with known transcriptional 
regulators in model yeast S. cerevisiae, it reveals that there are many close orthologs between 
them (MacPherson et al. 2006). Some of these TFs are only specific to C. albicans and it is 
suspected that these TFs may be responsible for C. albicans pathogenicity. An extensive 
transcription rewiring might have taken place in which the roles of homologous TFs have 
diverged in S. cerevisiae and C. albicans, making C. albicans a pathogenic fungus (Schillig and 
Morschhauser 2013). The identification and characterization of Zn(II)2Cys6 TFs in C. albicans 
have just started and so far, only some have been well studied.   
 Some of the known TFs that have been fully characterized in C. albicans and have 
orthologs in the model yeast S. cerevisiae are Fcr1p, Suc1p, Czf1p, and Cwt1p (Maicas et al. 
2005). Suc1p is the first Zn(II)2Cys6 TF identified in C. albicans and it affects an inducible α-
glucosidase for sucrose utilization (Kelly and Kwon-Chung 1992). In S. cerevisiae, the gene CZF1 
confers moderate pheromone resistance and the structure of the protein, Czf1p, has glutamine-
rich region in the central part and cysteine-rich region at the C-terminus (Whiteway et al. 
1992). Cwt1p is required for cell wall integrity in C. albicans, and Maicas et al. (2005) has 
predicted a presence of PAS, a C-terminal motif, that might be involved in eukaryotic signal 
transduction or dimerization events. FCR1 gene encodes Zn(II)2Cys6 protein that is homologous 
to S. cerevisiae’s TFs Pdr1p and Pdr3p and it behaves as a negative regulator of drug resistance 
in C. albicans (Maicas et al. 2005).  
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Among those 80 TFs that have been found in C. albicans, a subset of Zn(II)2Cys6 TFs are 
still poorly characterized and do not have homologs in other fungi. These poorly characterized 
TFs are called ZCF (Zinc Cluster Transcription Factor) and their functions and structures have 
not yet been fully elucidated. As shown in Figure 3, some ZCFs are expanded in C. albicans and 
other emerging pathogenic fungi but poorly conserved in nonpathogenic fungi. This may suggest 
that this family of TFs might have important roles in virulence that are evolutionarily conserved 
in pathogenesis.   
 
Figure 3. Certain ZCFs are only expanded in pathogenic fungi 
 
To date, the characterization and functions of these ZCFs have begun to unveil slowly. 
The Candida Genome Database records 39 ZCFs in their hits but four of them have been 
comprehensively investigated and have been named differently, previously known as ZCF12, 
ZCF33, ZCF36, and ZCF37. ZCF12 is now known as ECM22 and it is implicated in the regulation 
of genes involved in ergosterol synthesis and azole resistance. This ZCF has a homolog in S. 
cerevisiae and it is highly related to Upc2p (MacPherson et al. 2005). ZCF33/WOR2 is a regulator 
of white-opaque switching and it is a required gene to maintain the opaque state (Hernday et al. 
2013) while ZCF36/MRR1 controls the transcription of the multidrug transporter gene MDR in 
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C. albicans (Lohberger et al. 2014). Another regulator in the white-opaque switching, 
ZCF37/AHR1 specifically acts as an activator of white cell formation and a repressor of the 
opaque state (Wang et al. 2011).  
Since ZCFs encode for TFs, they can be involved in many different metabolic pathways. 
In fact, Khamooshi et al. (2014) has illustrated how ZCF can affect different pathways. Figure 4 
summarizes the pathways of GOA1, a gene that has a role in cell energy production, cross-talk 
among mitochondria and peroxisomes, non-glucose energy metabolism, maintenance of 
stationery phase growth, and prevention of premature apoptosis. GOA1 is positively controlled 
by the transcriptional regulators RBF1, HFL1, and DPB4 (Khamooshi et al. 2014). The blue 
arrows in Figure 4 represent biological processes that are resulted when the genes GOA1, RBF1, 
HFL1, and DPB4 were knocked out. The deletion of these four genes leads to the down-
regulation of the TFs in green font color and concurrent up-regulation of genes in red. For 
example, the deletion of either RBF1 or GOA1 causes ZCF15 to be down-regulated and ECM22 
to be up-regulated. This indicates that RBF1 or GOA1 could be involved in the same pathway. As 
TFs, ZCF could also have effects in the protein repertoires and pathway orchestration.  
 
 
Figure 4. Some of the ZCFs are involved in various pathways. The red color of the fonts indicates up-regulation 
of the gene while green means down-regulation. Reprinted from Khamooshi et al. (2014) 
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All the ZCFs that have been characterized are implicated in different pathways for 
virulence factors. For the purpose of this study, ten ZCFs have been selected based on 
interesting characterizations that have appeared in previous studies.  Throughout this research, 
analysis of these ZCFs was executed to discern whether they take parts in C. albicans’s 
pathogenesis. These ZCFs are summarized in Table 2 along with their reported phenotypes 
from Homann et al. (2009), Candida Genome Database’s descriptions, and a summary of their 
evolutions. Two of the ZCFs, ZCF6 and ZCF28, are unique because they are only present in C. 
albicans and not in other Candida species, potentially regulating pathways that differentiate C. 
albicans from other Candida species. 
In order to characterize some of these ZCFs, the dual approach will be used. First, the 
evaluation of the ability of individual ZCF deletion strains to survive murine macrophage killing 
will be carried out ex vivo. Second, testing the ability of the same deletion strains to resist 
various chemical stimuli in vitro will be conducted. The macrophage assay can show the 
contribution of ZCFs in resisting one of the most important components of the host’s immune 
system while the in vitro phenotypic profiling will determine some insight on the possible 
mechanisms of action of these ZCFs.  
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Gene ORF 
In vitro Phenotype from 
Homann et al. (2009) 
Candida Genome Database’s Description Evolution 
ZCF1 orf19.255   
Zn(II)2Cys6 transcription factor; transcript 
regulated during hypha formation; 5'-UTR intron; 
mutants show decreased colonization of mouse 
kidneys; flow model biofilm induced; spider 
biofilm induced 
ZCF1 has 1 homolog in C. albicans 19.254. ZCF1 is 
present in other Candida species as well as S. cerevisiae 
but the homolog orf19.254 is not present in many other 
Candida species.  
ZCF6 orf19.1497   
Putative transcription factor with zinc cluster 
DNA-binding motif 
ZCF6 ONLY found in C. albicans no homologs or 
orthologs in other Candida or S. cerevisiae.   
ZCF13 orf19.2646   
Predicted Zn(II)2Cys6 transcription factor; similar 
to but not the true ortholog of S. cerevisiae’s Hap1; 
mutants display decreased colonization of mouse 
kidneys 
ZCF13, NO homologs in C. albicans. Present but NOT 
expanded in most other Candida and NOT present in S. 
cerevisiae. 
ZCF15 orf19.2753   
Predicted Zn(II)2Cys6 transcription factor of 
unknown function; rat catheter biofilm induced 
ZCF15 has 4 homologs in C. albicans. Present in other 
pathogenic Candida (including C. tropicalis and C. 
dubliniesis) but not S. cerevisiae. 1 homolog is unknown 
and other 2 homologs are ZCF25 and ZCF26. 
ZCF24 orf19.4524   
Predicted Zn(II)2Cys6 transcription factor; 
caspofungin induced; Hap43-repressed 
ZCF24, 4 homologs in C. albicans. Present in most 
other Candida but not S. cerevisiae.  Homologs are 
TCC1 that regulates filamentation and interacts with 
TUP1.  Other 2 homologs are unknown.   
ZCF25 orf19.4568   Putative Zn(II)2Cys6 transcription factor 
ZCF25, 4 homologs in C. albicans. Present in other 
pathogenic Candida (including C. tropicalis and C. 
dubliniesis) but not S. cerevisiae. 1 homolog is unknown 
and other 2 homologs are ZCF15 and ZCF26. 
ZCF28 orf19.4767   
Zn(II)2Cys6 transcription factor; required for yeast 
cell adherence to silicone substrate; spider biofilm 
induced 
ZCF28, only present in C. albicans. NOT in any other 
Candida or S. cerevisiae. 
ZCF29 orf19.5133 
ΔΔorf19.5133 strains exhibited strong 
sensitivity to caffeine and menadione 
and strong resistance to 
fenpropimorph. 
Zn(II)2Cys6 transcription factor; mutants sensitive 
to caffeine and menadione, resistant to 
fenpropimorph; Hap43-repressed; mutants have 
decreased CFU in mouse kidneys and defects in 
filamentous growth; spider biofilm induced 
ZCF29, No homologs in C. albicans. Present but NOT 
expanded in most other Candida and NOT present in S. 
cerevisiae. 
ZCF31 orf19.5924 
Strong resistance to calcofluor white, 
strong sensitivity to copper and SDS, 
and weak sensitivity to fluphenazine, 
fenpropimorph, caffeine, and low pH. 
Zn(II)2Cys6 transcription factor of unknown 
function; mutant is sensitive to copper and SDS, 
and resistant to calcofluor white; required for yeast 
cell adherence to silicone substrate 
ZCF31, 4 homologs in C. albicans. Present in other 
pathogenic Candida (including C. tropicalis and C. 
dubliniesis) but not in S. cerevisiae. 1 homolog is BBC1 
and other 2 homologs are PGA55 and PGA58, GPI 
anchored proteins, involved in filamentation. 
ZCF34 orf19.6182 
Strong sensitivity to fluconazole and 
weak resistance to fenpropimorph. 
Zn(II)2Cys6 transcription factor; null mutant 
displays fluconazole sensitivity; Hap43-repressed 
gene; mutants display decreased colonization of 
mouse kidneys; required for yeast cell adherence to 
silicone substrate 
ZCF34, 2 homologs in C. albicans. POP2 is involved in 
antifungal resistance. Present in most other Candida and 
NOT present in S. cerevisiae. 
Table 2. List of ZCFs being studied 
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MATERIALS AND METHODS 
To improve the efficiency of the experiments, all of the protocols have been optimized for the 
specific strains used in this study. The complete protocols can be found in the Appendix 
section.  
 
Strains and Growth Conditions 
C. albicans ZCF deletion strains were obtained from the Fungal Genetic Stock Center 
(http://www.fgsc.net/) created by Oliver Homann as reported in his study (Homann et al. 2009). 
The deletion strains were grown in complete medium YPD (2% yeast extract, 1% peptone, and 
2% glucose) at 30C incubator. The wild type strain used for this study was SN250 constructed 
from Noble et al. (2010). 
Mouse macrophage leukemic cell line RAW264.7 was retrieved from Professor Reeta 
Rao lab’s frozen stock in liquid nitrogen for macrophage invasion study. Cells were quickly 
thawed and cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100units/mL 
penicillin G, and 100µg/mL streptomycin sulfate (Pen/Strep). This medium combination shall be 
termed DMEM+10% FBS+1% PenStrep. Cells were propagated at 37C incubator with 5% CO2 
in sterile 75cm2 tissue culture flasks. 
For transformation of C. albicans, the vector plasmid pSN105 (provided by Suzanne 
Noble) was grown in Luria-Bertani broth with 100µg/mL ampicillin at 37C. Saccharomyces 
cerevisiae BY4741 was thawed and propagated in YPD at 30C, the same growth condition as C. 
albicans.   
 
Strain Phenotype Genotype 
C. albicans SN250 Reference strain 
Arg- 
his1Δ/his1Δ, leu2Δ::C. dubliniensis HIS1 /leu2Δ::C. maltosa 
LEU2,arg4Δ /arg4Δ, URA3/ura3Δ::imm434, IRO1/iro1Δ::imm434 
S. cerevisiae BY4741  MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 
Table 3. Strains used in this study 
 
Macrophage Invasion Assay 
A 75cm2 tissue culture flask (T75) of macrophage RAW264.7 cells was prepared and 
grown up to at least 90% confluency. Meanwhile, an overnight culture of C. albicans ZCF 
deletion strain was subcultured 1:50 in fresh YPD and incubated for 5-6 hours. The old medium 
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from the T75 flask was removed and replaced with the same volume of fresh medium. The 
macrophage cells that attached to the surface of the flask were gently scraped using a cell 
scraper and transferred to a conical tube. A 100µL of the macrophage cell suspension was 
removed and mixed with 100µL Trypan Blue for cell counting.  
The macrophage cells were plated in the three wells of a 6-wells plate at a density of 2 x 
106 cells per well while the remaining wells were filled with just media. The plate was incubated 
at 37C for 6 hours to let the macrophage cells adhere to the surface of 6-wells plate. While 
waiting, the diluted overnight C. albicans culture was centrifuged and re-suspended in 
DMEM+10% FBS+1% PenStrep. For counting purposes, a small aliquot of the C. albicans 
suspension was diluted 1:100. The C. albicans suspension was diluted with the appropriate 
volume of DMEM+10% FBS+1% PenStrep to give 13.3 x 104 cells per well. The final ratio of the 
Candida:macrophage had to be 15:1. The C. albicans dilutions were added to all wells of the 6-
wells plate with the macrophage and incubated at 37C for 16 hours.  
The next day, all the wells were scraped using cell scrapers and the cells were lysed by 
vortexing with 0.05% Triton X-100 for 90 seconds. Aliquot of the lysed product was serially 
diluted 1:10 and plated at dilution 1:1,000 in YPD plates. The YPD plates were incubated in 
30C for 2 days for colony counting. A survival rate was generated from the ratio of 
macrophage-invaded and non macrophage-invaded C. albicans.  
 
Phenotypic Profiling in Stress Media 
Cultures of deletion strains were grown overnight in YPD at 30C. The cultures were 
diluted 1:10 with sterile water and the optical density at 600nm of each strain was measured 
using a spectrophotometer. The cultures were diluted with appropriate volume of sterile water 
to make a final OD600 of 1 for each strain. In a 96-well plate, a 1:5 serial dilution was performed 
and 10L of final dilution was spotted on YPD plates containing stress agents. For YPD plates 
with 0.04% SDS, only 3L of each dilution was spotted. Most of the plates were incubated at 
30C unless indicated otherwise. C. albicans grown in Spider media (1% mannitol, 1% nutrient 
broth, 0.2% K2HPO4, adjust to pH 7.2 prior to autoclaving) was incubated at 37C for 24 hours. 
The cells grown in other stress conditions were observed for a few days and any noticeable 
observations were recorded and scored compared to the wild type strain.  
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RESULTS 
 
ZCF13 and ZCF15 Aids in C. albicans’s Survival within Phagosomes 
 From the macrophage experiment, the C. albicans deletion strains’ ability to survive 
macrophage killing was compared to the wild type SN250 (Figure 5). The survival rate for wild 
type SN250 was normalized to 100% while deletion strains in general were neutralized by 
macrophage’s candidacidal activity. The results revealed seven deletion strains with lower 
survival rates and they were zcf6-/-, zcf13-/-, zcf15-/-, zcf24-/-, zcf28-/-, zcf29-/-, and zcf31-/-. 
However, out of those mentioned seven strains, only zcf13-/- and zcf15-/- were statistically 
significant when their survival rates were compared to that of wild type via student’s t-test (P- 
value < 0.05). The survival rates for zcf13-/- and zcf15-/- were reduced by more than 60%. 
Deletion of ZCF13 and ZCF15 genes made C. albicans more susceptible to macrophage killing, 
suggesting a role of these genes in resistance to mammalian host’s immunity. 
In contrast, there were three deletion strains with higher survival rates than the wild 
type, which were zcf1-/-, zcf25-/-, and zcf34-/-. The survival rate for zcf34-/- increased by 50% 
and has a statistical significance. The survival rates for zcf1-/- and zcf25-/- were not statistically 
significant and their rates only increased by 10-20%. C. albicans had a better survival without the 
ZCF34 gene, indicating that ZCF34 might be a potential repressor of an important pathway for 
resistance to mammalian immunity.  
 14 
 
Figure 5. The relative survival rates of C. albicans deletion strains generated from macrophage invasion assay 
normalized to wild type SN250. The asterisks indicate P-value < 0.05 
 
Validation of Phenotypes in Response to Stress Agents 
 Based on the phenotype screening reported by Homann et al. (2009), it is important to 
validate the findings and confirm the deletion strains that developed certain phenotypes 
different from the C. albicans wild type SN250. The C. albicans wild type and the deletion strains 
were grown in media added with various stress agents to assess their sensitivity and resistance. 
After a few days, the phenotypes were observed and compared with the wild type. The 
deletion strains showing similar phenotypes as the wild type was given a score of 0. If there 
were extreme reduction in the cell growth, they were scored negatively up to -4 for most 
extreme. An increase in growth gave positive score up to +4 for hyper-resistance. All the 
scores were put together to build a heatmap for a better visualization in Figure 6. The data 
shown are results of two sets of repeats or more. The results obtained by this study discover 
more phenotypes than Homann et al. (2009) had found.  
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Figure 6. Heatmap summarizing the phenotypes of ZCF-deficient C. albicans 
 
No Significant Phenotype in Lithium Chloride, High Temperature, and Spider Media 
From Figure 6, all the deletion strains displayed similar phenotypes as the wild type 
when grown in media containing 0.3M lithium chloride (LiCl), media incubated at 42ºC, and 
Spider media. The addition of LiCl usually induces osmotic stress and toxicity to C. albicans 
because the Li+ ions can inhibit some important metabolic pathways (Martins et al. 2008). None 
of the strains were affected by LiCl, which indicates that the deletion of ZCF genes did not 
impair their ability to neutralize the effects of LiCl.  
Growing C. albicans at higher temperature of 42ºC would normally affect its membrane 
fluidity, protein denaturation, and cause up-regulation of heat shock proteins. In S. cerevisiae, the 
heat-induced toxicity is most likely contributed by denatured protein and protein aggregates by 
loss of function and the inhibition of ubiquitin-proteasome system (Riezman 2004). None of the 
deletion strains also showed sensitivity or resistance to high temperature, meaning that none of 
ZCF genes are involved in the regulation of heat shock proteins.  
The Spider medium is a rich medium that strongly stimulates the hyphal growth and 
colony wrinkling through carbon starvation (Homann et al. 2009). Figure 7 summarizes the 
phenotypes exhibited by a negative control, positive control, wild type SN250, and C. albicans 
deletion strains. All the deletion strains displayed the same phenotypes as the wild type SN250 
as illustrated by some of the deletion strains. The cells had grown a few filaments around the 
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edges of the cell but their edges were not completely smooth compared to the negative control 
edt1-/-/cph1-/-. The strain edt1-/-/cph1-/- does not form any filaments since the gene responsible 
for filamentation on this strain has been knocked out. The positive control isolate 4639 was 
obtained from a clinical strain where it expressed resistance mechanisms even during carbon 
starvation and it had been characterized with abundant filaments in Spider media (Fazly et al. 
2013). Hyphal formation in C. albicans is associated with pathogenesis (Pukkila-Worley et al. 
2009) and since none of the deletion strains’ phenotypes were different from the wild type’s 
then, these evidences propose that the ZCF genes might not be involved in morphogenesis 
pathway.  
 
Figure 7. C. albicans grown in Spider medium.  
 
Sensitivity to Fluconazole 
Fluconazole is an antifungal drug that inhibits ergosterol biosynthesis and interferes with 
fungal cell membrane (Homann et al. 2009). The addition of 100M of fluconazole in the media 
resulted in the reduction of growth of C. albicans zcf29-/-, zcf31-/-, and zcf34-/-. Although not 
extreme, the result from zcf34-/- confirmed the phenotype reported by Homann et al. (2009) as 
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the growth reduced by 50% (see Figure 8). This finding confirms ZCF29, ZCF31, and ZCF34’s 
roles to help C. albicans survive against fluconazole’s mechanism of action.  
 
 
Figure 8. Phenotype of wild type SN250 and zcf34-/- in 100M fluconazole 
 
Phenotype to Calcofluor White 
Calcofluor white is a cell wall staining agent that has high affinity to chitin and tends to 
bind to chitin component of the fungal cell wall. It is often used to detect any defect in cell wall 
integrity pathways and hypersensitivity that is caused by mutations affecting chitin synthesis and 
deposition (Kachurina 2012). zcf6-/-, zcf15-/-, and zcf34-/- were slightly sensitive to calcofluor 
white and these genes might be involved in chitin synthesis. However, zcf31-/- grew better in 
the presence of calcofluor white (see Figure 9) and this slight resistance also confirm Homann 
et al.’s claim.  
 
Figure 9. Phenotype of wild type SN250 and zcf31-/- in 60M calcofluor white 
 
Phenotype to Sodium Dodecyl Sulphate (SDS) 
As a detergent, SDS causes damages to cell membrane, alters metabolism of carbon and 
induces oxidative stress response (Kachurina 2012). Some of deletion strains show slight 
resistance to SDS such as zcf1-/-, zcf13-/-, zcf15-/-, and zcf34-/- but the most extreme phenotype 
was observed in zcf31-/-, where none of the colonies grew (see Figure 10). zcf29-/- also got 
weakened by more than 50%. The hypersensitivity of zcf31-/- is confirmed by Homann et al. and 
ZCF31 and ZCF29 might be implicated in cell membrane formation and survival against SDS. 
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Figure 10. Phenotype of wild type SN250, zcf13-/-, zcf15-/-, zcf29-/- and zcf31-/- in 0.04% SDS 
 
Sensitivity to Caffeine 
A purine analogue, caffeine impairs the response to nutrient signaling and extensions of 
lifespan by interfering with the Target of Rapamycin (TOR) pathway by direct inhibition 
(Homann et al. 2009). Other than that, caffeine also affects variety fungal cellular processes. At 
concentration of 15mM of caffeine, zcf29-/- completely disappeared and zcf34-/- had reduced 
growth by about 50% (see Figure 11). This strongly suggests that ZCF29 might be involved in 
regulation of caffeine pathway. Homann et al. also reported zcf29-/-‘s strong sensitivity to 
caffeine however his claim about slight sensitivity in zcf31-/- is questionable since the zcf31-/- 
phenotype shown in Figure 11 look similar to the wild type’s phenotype.   
 
 
Figure 11. Phenotype of wild type SN250, zcf29-/-, zcf31-/-, and zcf34-/- in 15mM caffeine 
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Phenotype to Menadione 
Menadione is a quinone molecule that induces the production of reactive oxygen species 
through redox cycling (Homann et al. 2009). At concentration of 90M, the deletion strains 
generally exhibit more extreme phenotypes (see Figure 6). For example at concentration of 
80M, zcf1-/- was slightly resistant but with increased concentration of menadione, the 
resistance also increased. The same applies for zcf29-/-, where it was slightly sensitive at 80M 
and became more sensitive at 90uM. Homann et al. (2009) also reported a similar observation 
from zcf29-/- and it seems that the ZCF29 might provide protection against oxidative stress.   
The opposite trend was observed in zcf31-/- in which the resistance was reduced when the 
concentration of menadione was increased. zcf34-/- exhibited similar level of resistance at both 
concentrations, indicating the resistance might be independent from the amount of menadione 
in the media.   
 
C. albicans Transformation 
Because C. albicans is a diploid fungus, inserting a copy of the ZCF genes back to the 
deletion strains can potentially rescue the wild type phenotype. This approach can be used to 
further characterize the ZCF genes and their functions. As a part of this study, C. albicans 
transformation protocols had been developed and optimized. A number of sources including 
Zeng et al. (2014) has reported C. albicans’s low transformation efficiencies and to address this 
issue, the transformation was done in multiple steps using S. cerevisiae and Escherichia coli to 
improve the success. The flowchart of the protocols can be viewed in Figure 12. The flowchart 
summarizes the complete C. albicans transformation protocols that can be found in the 
Appendix section. The insertion of ZCF genes was aided with the vector plasmid pSN105 
obtained from Suzanne Noble. This plasmid contains uracil, arginine, and ampicillin-resistance 
markers that are useful for selecting cells that have fully integrated the genes into the plasmid. 
The plasmid construction process is shown in Figure 13.   
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Figure 12. Flowchart summarizing C. albicans 
transformation processes 
 
Figure 13. Construction of plasmid for C. albicans 
transformation
Check the ZCF integration by PCR using  
5' and 3' junctions primers at the LEU2 locus 
Genomic extraction with phenol:chloroform 
Select for Arg+ colonies by  
growing in YNB-Arg plates 
C. albicans transformation 
Digest plasmid with PmeI 
Confirm plasmid integration by PCR  
using ZCF check primers 
E. coli miniprep to recover plasmid construct 
Select for AmpR colonies by  
growing in LB+Amp plates 
E. coli transformation via HeatShock  
or Electroporation 
Confirm plasmid integration by PCR  
using ZCF check primers 
Yeast miniprep with acid-washed beads  
to obtain plasmid 
Select for Ura+ colonies by  
growing in SC-Ura plates 
Gap repair cloning and  
S. cerevisiae transformation 
A 
B 
C 
D 
 21 
First, the desired ZCF gene is amplified by PCR using SN250 as the template. The PCR 
product will contain the ZCF gene and extra nucleotides upstream and downstream of the gene 
for homologous recombination. The plasmid pSN105 then is digested with restriction enzyme 
BmgBI to cut the plasmid at the site where homologous recombination will occur (see Figure 
13A). The amplified ZCF gene and the cut plasmid are incubated together with the S. cerevisiae 
BY4741 cells and single-strand salmon sperm DNA for transformation. Gap-repair cloning 
method is particularly used for this transformation in order to improve efficiency and 
integration (Gerami-Nejad et al. 2013). The successful integration of plasmid in S. cerevisiae can 
be detected by growth of colonies in SC-Ura plates.  
The integrated plasmid is renamed to pCJ### (list of plasmids is available in Appendix) 
and isolated for further cloning in electrocompetent cell E. coli DH5 by electroporation. If the 
E. coli transformation is successful, colonies will grow in LB plates supplemented with ampicillin. 
The plasmid from E. coli is recovered by miniprep and cut with restriction enzyme PmeI to 
isolate the ZCF plus ARG4 gene (see Figure 13B) that have extra nucleotides upstream and 
downstream that are homologous to the leu2 gene locus of the C. albicans deletion strains (see 
Figure 13C). The transformation in C. albicans integrates the ZCF gene into the deletion strain 
and the colonies are selected by growing the cells in Yeast Nitrogen Base plates without 
arginine (YNB-Arg). The integration can be confirmed by PCR to check the presence of genes 
in 5’ junction of the leu2 locus and 3’ junction of the ARG4 (see Figure 13D).  
This transformation protocols had been done successfully to restore ZCF1, ZCF13 and 
ZCF15 back to their respective deletion strains and the success of the transformation had been 
confirmed through PCR. Unfortunately, these ZCFs do not have defined phenotypes between 
the deletion strains and wild type therefore it is difficult to perform complementation analysis 
and assess if the single copy gene can rescue the wild type phenotype.  
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DISCUSSION 
From all the results of the experiments done in this study, only certain deletion strains 
displayed interesting phenotypes and characteristics. The data from the macrophage killing 
suggest that ZCF13 and ZCF15 genes might play an important role for C. albicans’s survival 
against the host’s immunity since the deletion strains became more susceptible by at least 2-
fold. On the other hand, ZCF34 might be a potential repressor for C. albicans’s survival since the 
deletion strain showed a much higher survival rate than of the wild type. The macrophage 
invasion assay is an effective approach to study macrophage’s action against C. albicans. 
However, this assay is limited to the candidacidal action of macrophage. The invasion assay 
could be extended to using neutrophil as the main challenger of C. albicans instead of 
macrophages since neutrophil makes up the most of human’s innate immune system and the 
results can simulate the host-pathogen interaction better.  
The results from this macrophage assay also require more repeats to confirm the 
mentioned findings since this experiment was only carried out once due to time constraint. The 
initial protocol of the assay had slightly modified steps in which after the 16-hours incubation, 
the cells were lysed with 0.02% Triton X-100 without vortexing and washed with water for 
two times. The cell washing with water generated problems during the experiment since the 
pellets from centrifugation did not clump together. As a consequence, some of the cells got 
discarded with the supernatants and the number of colonies varied greatly after serial dilution, 
creating a high technical “noise” for the data.  
In an effort to solve this issue, different macrophage killing protocols were reviewed and 
it was found that by eliminating the cell-washing step, the variability or the noise could be 
reduced. The optimized macrophage killing protocol removed the cell-washing step and added a 
step of vortexing the cells with 0.05% Triton X-100 to improve cell lysis as recommended by 
Lopes da Rosa et al. (2010). Compared to the data from the initial macrophage assay protocol, 
the optimized protocol produced more consistent results and less noise. However the similar 
trends were still observed, supporting the results of ZCF13, ZCF15, and ZCF34. The 
macrophage invasion assay should be repeated at least three times for each strain to increase 
the confidence of the results. 
The in vitro phenotypic profiling has confirmed most of the Homann et al.’s report. The 
data show how C. albicans deletion strains performed in various stress conditions and also 
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provide hints about the ZCF genes involvement in certain pathways. zcf29-/- completely lost its 
ability to form colonies in the presence of caffeine, meaning in wild type, ZCF29 helps C. albicans 
to metabolize caffeine and neutralize caffeine’s toxic effect. In addition, zcf31-/- also showed the 
same phenotype as zcf29-/- except it was in SDS. ZCF31 potentially is involved in cell membrane 
formation and neutralization of SDS molecule. Both zcf29-/- and zcf31-/- exhibited the most 
extreme phenotypes in this experiment and further studies are encouraged to investigate their 
functions. If these genes are important for C. albicans’s survival or pathogenesis, this information 
can be useful for designing a drug that targets ZCF29 and ZCF31.  
 ZCF6 and ZCF28 were initially selected in this study as potential candidates who might 
have diversified C. albicans from other Candida species since they are only present in C. albicans. 
However, the results from this study have not provided enough evidence to confirm this 
hypothesis and it seems that these genes might not be directly involved in virulence. The data 
from the macrophage invasion assay reveal that zcf6- and zcf28-deficient C. albicans were 
susceptible to macrophage but the survival rates are not statistically significant. From the 
phenotype characterization, zcf6-/- growth was slightly reduced in the presence of calcofluor 
white however zcf28-/- did not show any distinct phenotype from the wild type. The other 
fungal organism that shares the same ZCF6 gene is Aspergillus nidulans, a non-pathogenic 
filamentous fungus and a model organism, while C. albicans shares ZCF28 with Neospora crassa, 
an ascomycete known as a red bread mold. This might indicate that ZCF6 and ZCF28 are not 
involved with pathogenesis pathways but again, further studies are needed to confirm this.  
 With the optimization of the transformation protocols, the complementation analysis 
will be a promising prospect for further ZCF characterization. Complementation analysis will be 
beneficial in determining if a single copy of the ZCF genes will produce similar phenotype as the 
wild type. Since ZCF encodes for fungal-specific transcription factors, investigating their gene 
functions and involvement in biochemical pathways in C. albicans can improve the current 
understanding of C. albicans’s pathogenesis and potentially provide new drug targets that will 
help treat those who suffer from Candida infections. Some other assays that can be useful to 
determine the ZCF’s roles in metabolic pathways include RNA and ChIP sequencing. Both are 
novel technologies that have been widely used to reveal gene functions.  
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APPENDIX A: MACROPHAGE INVASION ASSAY 
PROTOCOL 
Protocol adapted by Jain (2014) from Lopes da Rosa et al. (2010) 
 
 
1. Start 5mL overnight cultures of C. albicans deletion strains in YPD at 300C. 
 
2. On the day of the experiment, dilute 100µl of the culture in 5mL of fresh YPD and let 
them grow for 4-5 hours. 
 
3. Aspirate the used media from the RAW264.7 macrophage flask and add fresh DMEM 
supplemented with 10% FBS, 100U/mL penicillin and 100µg/mL streptomycin.  Add 
about 15mL for one T75 flask. 
 
4. Scrape the cells from the flask using a scraper and pipette the macrophage up and down 
a few times to separate any clumps of cells.  
 
5. Transfer to a 50mL tube and take 100µl of the suspension to an Eppendorf tube. 
 
6. To this Eppendorf tube, add 100µl of 0.4% Trypan Blue and mix. 
 
7. Clean a hemocytometer with 70% ethanol. Put a clean coverslip on it and add 10μL of 
macrophage-trypan blue mix to one side of the hemocytometer.  
 
8. Pick three large squares that best represent the population number of the cells and 
count the cells in those squares.  
 
9. Calculate the concentration of cells by using this formula 
 
10. Concentration of cells    verage of cells in 3 squares x   ,    x 2  
 
11. Determine the volume of macrophage suspension to get 2 × 106cells/well for each well 
in the 6-wells plate. Do this for as many wells as you need. 
 
12.  olume of suspension needed   
2 x     cells well
concentration of cells 
 x number of wells to be filled 
 
13. Separate the suspension needed in a 15mL conical tube. Centrifuge at 2000 rpm for 5 
minutes.  
 
14. Remove supernatant and re-suspend in the fresh medium for 1mL/well. For example, if 
adding macrophages to 3 wells, then re-suspend pellets in 3mL of fresh medium.  
 
15. Add 1mL/well of fresh medium to control wells (without macrophages).  
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16. Incubate all the plates at 370C and 5% CO2 for 6 hours so that the cells can adhere to 
the surface.   
 
17.  A little before the 5 hours are up, take the C. albicans cultures and centrifuge them for 
5 minutes at 4000 rpm.  
 
18. Re-suspend cultures in the same volume of fresh DMEM.  
 
19. Count the number of cells/mL for the C. albicans strains using the hemocytometer. Make 
a 1:100 dilution to obtain countable number of cells.  
 
20. Add the appropriate volume of the candida culture to get 13.3 × 104cells/well (in both 
with and without macrophages) since you want the ratio of the Candida:macrophage to 
be 1:15, and to make up the final volume of 2mL in each well.  
 
21.  Incubate all the plates at 370C and 5% CO2 for 16 hours.  
 
22.  On the next day, scrape the cells using cell scrapers.  
 
23. Add the 2mL from the plate to 50mL conical tube containing 18mL 0.05% Triton X-100. 
 
24. Wash each plate twice with 2mL of 0.05% Triton X-100 each and add to the respective 
tube to get the final volume of ~24mLs. 
 
25. Prepare a 96-well plate for 1:10 serial dilution and add 270μL of sterile water to all 
columns except for column 1.  
 
26. Vortex the tubes for 90 seconds and transfer 200μL of vortexed suspension to the 
column 1 of 96-well plate. Quickly make a serial dilution by taking 30μL of the 
suspension to the next row, pipet up and down, and take 30μL for the next row. Do 
the same thing until dilution 103.   
 
27. Repeat for all the tubes. 
 
28. Plate 100μL of dilution 103 in YPD and incubate for 2 days at 30C.  
 
29. Count the colony forming units (cfu) on each plate and calculate the % survival by taking 
the ratio of cfu obtained from Candida and macrophage to cfu obtained for Candida 
alone. 
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APPENDIX B: TRANSFORMATION PROTOCOLS 
The following protocols have been designed and optimized for strains and conditions 
mentioned in this study. For the outline of the transformation process, please revise the steps 
in Figure 12. For E. coli miniprep, restriction enzymes, and PCR, please follow the protocols 
attached with the kit and the manufacturer instruction.  
 
S. cerevisiae Transformation and Gap-Repair Cloning 
Protocol adapted from Gerami-Nejad et al. (2013)  
 
1. Pick a colony of S. cerevisiae strain BY4741 and grown in 5mL of YPD overnight at 30°C. 
 
2. Inoculate 50mL of fresh YPD with 1.5mL of the overnight culture and incubate at 30°C 
for 5-6 hours in shaker or until the OD600 reaches 1-1.5. (Initial OD600 for the 50mL 
culture should be around 0.1).  
 
3. Centrifuge cultures at room temperature in clinical centrifuge at 3000 rpm for 5 
minutes. 
 
4. Wash with 5mL LiOAc mix (1 x TE pH 8, 100mM lithium acetate). 
 
5. Centrifuge at room temperature in clinical centrifuge at 3000 rpm for 5 minutes. 
 
6. Re-suspend in 1mL LiOAc. 
 
7. Mix 100µL cells with 10µL single-strand salmon sperm DNA, 1µL of BmgBI-digested 
pSN105 and 10µL PCR product of desired ZCF. 
 
8. Add 500µL PEG mix (1 x TE pH 8, 100mM lithium acetate, 40% PEG 3350). 
 
9. Mix well by pipetting and incubate for 30 minutes at room temperature. 
 
10. Heat shock at 37-42°C for 5 minutes. 
 
11. Centrifuge at approximately 3600 rpm for 3 minutes, at room temperature. 
 
12. Remove PEG mix manually with pipette. Wash gently with 0.5mL YPD.  
 
13. Re-suspend in 100µL water and plate in SC-Ura.  
 
14. Grow for 48 hour at 30°C incubator. 
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Isolation of Plasmid DNA from Yeast Using the QIAprep Spin Miniprep Kit 
Protocol adapted from Jones (2001) 
 
1. Inoculate a single colony into 5mL of SC-Ura liquid medium and grow the culture 
overnight (16-24 hours) at 30°C. 
 
2. Harvest the cells by centrifugation for 5 minutes at 5000 x g and re-suspend cells in 
250μL Buffer P1 containing 0.1mg/mL RNase A. Transfer the cell suspension to a 1.5mL 
microcentrifuge tube. 
 
3. Add 100μL of acid-washed glass beads (Sigma G-8772) and vortex for 5 minutes. Let 
stand to allow the beads to settle. Transfer supernatant to a fresh 1.5mL 
microcentrifuge tube. 
 
4. Add 250μL lysis buffer P2 to the tube and invert gently 4–6 times to mix. Incubate at 
room temperature for 5 minutes. 
 
5. Add 350μL neutralization buffer N3 to the tube and invert immediately but gently 4–6 
times. 
 
6. Centrifuge the lysate for 10 minutes at maximum speed in a tabletop microcentrifuge 
(13,000 rpm or ≥10,000 x g). Meanwhile, place a QIAprep Spin Column in a 2mL 
collection tube. 
 
7. Transfer the cleared lysate from step 6 to QIAprep Spin Column by decanting or 
pipetting. 
 
8. Centrifuge for 1 minute at maximum speed. Discard flow-through. 
 
9. Wash QIAprep Spin Column by adding 0.75mL of Buffer PE and centrifuging 1 minute at 
maximum speed.   
 
10. Discard flow-through and centrifuge for an additional 1 minute to remove residual wash 
buffer. 
 
11. Place QIAprep Spin Column in a clean 1.5mL microcentrifuge tube. To elute DNA, add 
25μL of Buffer EB (10mM Tris·Cl, pH 8.5) or water to the center of each QIAprep Spin 
Column, let stand for 1 minute, and centrifuge for 1 minute. 
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High Efficiency Electrotransformation of E. coli (Electroporation) 
Protocol adapted from Bio-Rad (n.d.) and Invitrogen (2013) 
 
1. Thaw the electrocompetent cells on ice. For each sample to be electroporated, place a 
1.5mL microfuge tube and a 0.2cm electroporation cuvette on ice. 
 
2. In a cold, 1.5mL microfuge tube, mix 25µL of the cell suspension with 5µL of DNA 
(DNA should be in a low ionic strength buffer such as TE). Mix gently with pipette tip 
and incubate on ice for ~1 minute. Do not mix by pipetting up and down.  
 
3. Set the MicroPulser to “Ec2”. 
 
4. Transfer the mixture of cells and DNA to a cold electroporation cuvette and tap the 
suspension to the bottom.  
 
5. Place the cuvette in the chamber slide. Push the slide into the chamber until the cuvette 
is seated between the contacts in the base of the chamber. Pulse once.  
 
6. Remove the cuvette from the chamber and immediately add 1mL of SOC medium to 
the cuvette. Quickly but gently re-suspend the cells with a sterile Pasteur pipette.  
 
7. Transfer the cell suspension to microfuge tube and incubate at 37°C for 1.5 hour, 
shaking at 225 rpm. 
 
8. Warm LB+Amp plates at 37°C for 30 minutes.   
 
9. Spread 100µL of cell suspension in LB+Amp plates. 
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High Efficiency Chemical Transformation of E. coli (Heat Shock) 
Protocol adapted from Bio-Rad (n.d.) 
 
1. Centrifuge the vials containing the ligation reaction briefly and place on ice.  
 
2. Thaw, on ice, one 50µL vial of One Shot® cells for each transformation.  
 
3. Pipet 5µL of DNA directly into the vial of competent cells and mix by tapping gently. Do 
not mix by pipetting up and down.  
 
4. Incubate the vials on ice for 30 minutes.  
 
5. Incubate for exactly 30 seconds in the 42°C bath and place them on ice.  
 
6. Add 1mL of SOC medium to each vial.  
 
7. Incubate tubes at 37°C for 1.5 hour, shaking at 225 rpm. 
 
8. Warm LB+Amp plates at 37°C for 30 minutes.   
 
9. Spread 100µL of cell suspension in LB+Amp plates. 
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Transformation of C. albicans 
Protocol adapted from Hernday et al. (2010) 
 
1. Grow one colony of the knockout C. albicans strain in 5mL of YPD overnight at 30°C. 
 
2. Inoculate 50mL of fresh YPD with 1.5mL of the overnight culture and incubate at 30°C 
for 5-6 hours in shaker or until the OD600 reaches 1-1.5 (Initial OD600 for the 50 mL 
culture should be around 0.1).  
 
3. Centrifuge for 2 minutes at 1000 g and discard supernatant. 
 
4. Re-suspend in 900L LiOAc/TE and transfer to a microcentrifuge tube. 
 
5. Pellet for 1 minute at 1000 g and discard supernatant. 
 
6. Wash two more times with 900L LiOAc/TE then re-suspend in 400L final volume 
with LiOAc/TE. 
 
7. In a separate microfuge tube mix (in order) the following: 
a. 10L of 10mg/mL denatured Salmon Sperm DNA (prepared by boiling 2 minutes 
then snap cooling in ice water)  
b. 1g of E. coli miniprep 
c. 200L washed cells in LiOAc/TE 
d. 1mL PEG mix 
 
8. Incubate overnight at room temperature. 
 
9. Heat shock at 44°C for 15 minutes. 
 
10. Pellet for 1 minute at 1000g and discard supernatant. 
 
11. Wash one time with 1mL sterile water. 
 
12. Re-suspend in 150L final volume with sterile water. 
 
13. Plate on YNB-Arg media and incubate at 30°C for 2–3 days. 
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APPENDIX C: PLASMIDS CONSTRUCTED IN THIS STUDY 
Plasmid Database No.  Description Host Organism 
pCJ101 F190  Gap repair pSN105 digested with BmgBI and MscI + ZCF15 S. cerevisiae 
pCJ102 F191 Gap repair pSN105 digested with BmgBI + ZCF15 S. cerevisiae 
pCJ103 F192 Gap repair pSN105 digested with BmgBI and MscI + ZCF1 S. cerevisiae 
pCJ104 F193 Gap repair pSN105 digested with BmgBI + ZCF1 S. cerevisiae 
pCJ105 F194 Gap repair pSN105 digested with BmgBI + ZCF13 S. cerevisiae 
pCJ106 F195 ZCF15 cloned in pSN105 via gap repair colony 1 E. coli 
pCJ107 F196 ZCF15 cloned in pSN105 via gap repair colony 2 E. coli 
pCJ108 F197 ZCF13 cloned in pSN105 via gap repair colony 1 E. coli 
pCJ109 F198 ZCF13 cloned in pSN105 via gap repair colony 2 E. coli 
pCJ110 F199 ZCF1 cloned in pSN105 via gap repair colony 1 E. coli 
pCJ111 F200 ZCF1 cloned in pSN105 via gap repair colony 2 E. coli 
pCJ112 
F201 ZCF15+/- (obtained by transforming zcf15-/- with PmeI digested 
pCJ106)   
C. albicans 
pCJ113 
F202 ZCF13+/- (obtained by transforming zcf13-/- with PmeI digested 
pCJ108 colony 1)   
C. albicans 
pCJ114 
F203 ZCF13+/- (obtained by transforming zcf13-/- with PmeI digested 
pCJ108 colony 2 )   
C. albicans 
pCJ115 
F207 ZCF1+/- (obtained by transforming zcf1-/- with PmeI digested 
pCJ110)   
C. albicans 
pCJ116 F210 Gap repair pSN105 digested with BmgBI + ZCF29  S. cerevisiae 
pCJ117 F211 Gap repair pSN105 digested with BmgBI + ZCF31 colony 1 S. cerevisiae 
pCJ118 F212 Gap repair pSN105 digested with BmgBI + ZCF31 colony 2  S. cerevisiae 
pCJ119 F213 Gap repair pSN105 digested with BmgBI + ZCF34 colony 1  S. cerevisiae 
pCJ120 F214 Gap repair pSN105 digested with BmgBI + ZCF34 colony 2  S. cerevisiae 
pCJ126 F224 Gap repair pSN105 digested with BmgBI + ZCF6  S. cerevisiae 
pCJ127 F225 Gap repair pSN105 digested with BmgBI + ZCF24  S. cerevisiae 
pCJ128 F226 Gap repair pSN105 digested with BmgBI + ZCF28  S. cerevisiae 
pCJ129 F227 Gap repair pSN105 digested with BmgBI + ZCF34  S. cerevisiae 
pCJ130 F228 Gap repair pSN105 digested with BmgBI + ZCF25  S. cerevisiae 
pCJ131 F229 Gap repair pSN105 digested with BmgBI + ZCF31  S. cerevisiae 
pCJ132 p277 ZCF6 cloned in pSN105 via gap repair E. coli 
pCJ133 p278 ZCF24 cloned in pSN105 via gap repair E. coli 
pCJ134 p279 ZCF34 cloned in pSN105 via gap repair E. coli 
pCJ135 F229 Gap repair pSN105 digested with BmgBI + ZCF29  S. cerevisiae 
pCJ136 p280 ZCF25 cloned in pSN105 via gap repair E. coli 
pCJ137 p281 ZCF28 cloned in pSN105 via gap repair E. coli 
pCJ138 p282 ZCF29 cloned in pSN105 via gap repair E. coli 
pCJ139 p283 ZCF31 cloned in pSN105 via gap repair E. coli 
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APPENDIX D: PRIMERS USED IN THIS STUDY 
Database 
No 
Oligonucleotides Sequence 
602 3''junc compl LEU2 R REV  CAATAACTACCTCGGCACCTT 
601 3'junc compl LEU2 F FWD GTATCGCCTTTGGGATGTCTAT 
600 5' junc Leu2 forward GTAACGACGCCAAATCTCAATAC 
584 Check 5' jun +/- REV  GGATTGTGCGTCGATCAATAA 
569 F ZCf15 check  GGCAACCACCAAGTCATCTA 
629 Rev 5' ZCF15-/- pro ATCTTAACCTTCTAGTCCACGTAAA 
590 Zcf 1 FWD TCGACAGTGATGCACCTAATC 
591 Zcf 1 REV CCCAATTTCTCCTCCACTACTAC 
603 Zcf1 check qPCR rev  ACTGCAGCTGCCATTCTT 
592 zcf1 F gap repair (BmGBI) GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACTGTTCAAGTCTGTCACTTCC 
594 
zcf1 gap repair  
(BmgBI reverse) 
CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACCATCAACAAGAGGGTCCAAG 
619 ZCF6 BmgBI cloning FWD GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACCACCACCGATAGCAACTCAA 
620 ZCF6 BmgBI cloning REV CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACATGGACGACCCAAATTCACA 
636 ZCF6 check FWD CCCACCTGTTAAACGACCAA 
637 ZCF6 check REV CTGCTGCTACTGGTGCTATT 
598 Zcf13 check CCTTCTGTAACGACACCATCTT 
599 Zcf13 check GCCATTGGCGTTTCCATTAC 
595 Zcf13 for gap (BmgBI) GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACCCATCTTCACAGGCCAATCT 
597 
zcf13 repair (reverse 
BmGBI) 
CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACAGTCCGCACTGAGACAATTC 
604 zcf13 Rev qPCR TAGTTGGTGACAACACTCCATC 
570 ZCf15 check  REV CTGTGGTACATTGCTGCTACT 
587 ZCF15 gap for (BmgBI) GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACAGGAGGAGGAGGACAAGAAA 
589 zcf15 gap rev BmgI CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACATCAAACATCAGCAGGAGGA 
623 ZCF24 BmgBI cloning FWD GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACCGCAACACCAGGGACAATTA 
624 ZCF24 BmgBI cloning REV CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACTGCCACACAAAGCAGAATCA 
630 ZCF24 check FWD GGTGGGTTTCCGTGTCTAAA 
631 ZCF24 check REV GGAACTCCAACACGAGGTAA 
625 ZCF25 BmgBI cloning FWD TTGTAAAATTACAATTGGTATTTTCAACCAATATTACCACACTTGCGGAACCGGAATTGT 
626 ZCF25 BmgBI cloning REV CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACAGCAGCTACTGGGTCTAACT 
632 ZCF25 check FWD ACAGTCTCAGGACCCAGTT 
633 ZCF25 check REV TGCTTGCCGTCTTGAGAAA 
621 ZCF28 BmgBI cloning FWD GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACGGTAGCAACGTGTGGTAGTT 
622 ZCF28 BmgBI cloning REV CCTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACTCCTCTTCGGGTGGTGTAT 
638 ZCF28 check FWD TGACACTACACTTGGGTTTG 
639 ZCF28 check REV GCTGGTGATTCATCGTAGTT 
615 ZCF29 BmgBI cloning FWD GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACAGTATCGCCACTTCACCAA 
616 ZCF29 BmgBI cloning REV CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACCACCACCAACAAACAGAACA 
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617 ZCF29 check FWD  AGCACTGGTGTCAGCATAAA 
618 ZCF29 check REV  GTGTTTGTGAGCGAAGGAATAAA 
609 ZCF31 check FWD GCCTCCAAGTATCCCAACAA 
610 ZCF31 check REV CGGTAGACGCCAATTCTTCA 
607 ZCF31 cloning BmgBI FWD GTAAAATTACAATTGGTATTTTCAACCAATATTACCACACCGGAATCACATCACCCAAGA 
608 ZCF31 cloning BmgBI REV CCTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACAACCCTCAACCACCACAAA 
613 ZCF34 check FWD GTGCCTCATGCCACAAATC 
614 ZCF34 check REV GGCTCGGTATGTATGCTTCT 
611 ZCF34 cloning BmgBI FWD TGTAAAATTACAATTGGTATTTTCAACCAATATTACCACACGCTGGACCTTGGACTTTGA 
612 ZCF34 cloning BmgBI REV CTATCTCTCTTTTTTTTGCCCATTTGAGTTAGTGCATGACCGGCTTTGCTTGAACTTACG 
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